NORDITROPIN, created in 1985 (Switzerland), from 307 sister brands and 2214 competing brands. NORDITROPIN is owned by NOVO-NORDISK A/S, listed on the stock exchange of Francfort NORDITROPIN belongs to the Biotechnology business sector.
Investment simulator :
Portfolio valuation
NOVO-NORDISK A/S
(NORDITROPIN)
over 5 years*
EUR 693.88